APLT Research and Charts

APLT - Applied Therapeutics Inc (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-09-12)

Last 0.42	Change ⇓ -0.02 (0.00%)	Volume 802,201
	Open 0.43	High 0.45	Low 0.42

8EMA (Daily) 0.46	40EMA (Daily) 0.46	50EMA (Daily) 0.46	STO (Daily) 8.857	MACD Hist (Daily) -0.022
8EMA (Weekly) 0.453	40EMA (Weekly) 1.24	50EMA (Weekly) 1.55	STO (Weekly) 65.588	MACD Hist (Weekly) 0.211


Company Profile
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.